Oelkers W, L'age M
Klin Wochenschr. 1976 Jul 1;54(13):607-12. doi: 10.1007/BF01469025.
In 7 out-patients with Addison's disease, plasma renin activity (PRA), plasma concentrations of angiotensin II (AT II), renin substrate (PRS), potassium, sodium and total protein, hematocrit, blood pressure, heart rate and body weight were studied after 2 weeks each on 2 mg of dexamethasone, 25 mg hydrocortisone (HC), 25 mg HC + 0.05 mg 9-alpha-fluorohydrocortisone (FC), 25 mg HC + 0.1 mg FC and 25 mg HC + 0.2 MG FC. Four further patients were less extensively studied. Mean PRA (upper normal limit, ambulatory: 12 ng AT I-ml-1-h-1) after the 5 steps of incremental substitution, starting with dexamethasone, was 192, 59, 38, 24 and 9 ng AT I-ml-1-h-1 rsp. PRS did not change with increasing substitution. PRA and AT II were significantly correlated (r = 0.91; p less than 0.0001) and proved to be the most sensitive parameters of insufficient mineralocorticoid substitution. With decreasing significance, PRA also correlated with plasma protein concentration, plasma sodium concentration (negative), delta body weight (negative), heart rate, delta mean blood pressure (negative) and plasma potassium concentration. PRA or AT II measurements are useful clinical tools to control mineralocorticoid substitution in Addisonian patients. Inappropriately high substitution can be prevented by keeping PRA in the upper normal range.
对7例艾迪生病门诊患者,分别给予2mg地塞米松、25mg氢化可的松(HC)、25mg HC + 0.05mg 9-α-氟氢化可的松(FC)、25mg HC + 0.1mg FC和25mg HC + 0.2mg FC治疗,每2周为一个阶段,分别研究了各阶段患者的血浆肾素活性(PRA)、血管紧张素II(AT II)血浆浓度、肾素底物(PRS)、钾、钠、总蛋白、血细胞比容、血压、心率和体重。另外4例患者进行了较少项目的研究。从地塞米松开始,经过5个递增替代步骤后的平均PRA(动态正常上限:12ng AT I-ml-1-h-1)分别为192、59、38、24和9ng AT I-ml-1-h-1。随着替代量增加,PRS无变化。PRA与AT II显著相关(r = 0.91;p < 0.0001),并被证明是盐皮质激素替代不足最敏感的指标。PRA还与血浆蛋白浓度、血浆钠浓度(负相关)、体重变化量(负相关)、心率、平均血压变化量(负相关)和血浆钾浓度存在相关性,但显著性逐渐降低。PRA或AT II测量是控制艾迪生病患者盐皮质激素替代的有用临床工具。通过将PRA维持在正常上限范围内可防止替代量过高。